| ACOR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ACOR market cap history going back to 2/19/2010:
Also see: ACOR Shares Outstanding History and ACOR YTD Return |
ACOR Market Cap History — Acorda Therapeutics Capitalization Over Time
As of 3/27/2024 Acorda Therapeutics has a market cap of 14.79 million. Investors often follow the ACOR market cap history to compare the size of the company over time.
This page shows ACOR market capitalization trends over time, with 56 market cap datapoints presented, dating back to 2/19/2010.
| ACOR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACOR Historical Market Cap: -26.82% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACOR Stock Price Chart |
| About Acorda Therapeutics Inc |
| Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Co. markets Inbrija (levodopa inhalation powder), which is approved for intermittent treatment of episodic motor fluctuations, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija utilizes Co.'s ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Co. also markets Ampyra (dalfampridine) extended release tablets, 10 mg for improving walking in patients with multiple sclerosis. Ampyra is marketed as Fampyra outside the U.S. We show 56 historical shares outstanding datapoints in our ACOR shares outstanding history coverage, used to compute ACOR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACOR market cap history over the course of time is important for investors interested in comparing ACOR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACOR versus a peer is one thing; comparing ACOR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACOR can fluctuate over the course of history. With this page we aim to empower investors researching ACOR by allowing them to research the ACOR market cap history. |
| ACOR Current Stock Quote |
Quotes delayed 20 minutes  Free ACOR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| ACOR Share Performance |
| Market Cap Peers |
| Acorda Therapeutics (ACOR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ACRS Market Cap History ACRV Market Cap History ACRX Market Cap History ACST Market Cap History ACTU Market Cap History ACXP Market Cap History ADGI Market Cap History ADIL Market Cap History ADMA Market Cap History ADMP Market Cap History More Healthcare companies » |
ACOR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
